The optimal regimen of brentuximab vedotin for CD30(+) cutaneous lymphoma: Are we there yet? Journal Article


Authors: Geller, S.; Myskowski, P. L.; Kim, Y. H.; Moskowitz, A.; Horwitz, S.
Article Title: The optimal regimen of brentuximab vedotin for CD30(+) cutaneous lymphoma: Are we there yet?
Journal Title: British Journal of Dermatology
Volume: 178
Issue: 2
ISSN: 0007-0963
Publisher: Blackwell Publishing  
Date Published: 2018-02-01
Start Page: 571
Language: English
DOI: 10.1111/bjd.16052
PROVIDER: scopus
PUBMED: 29023638
DOI/URL:
Notes: Letter -- Export Date: 1 March 2018 -- Source: Scopus
Altmetric Score
MSK Authors
  1. Steven M Horwitz
    368 Horwitz
  2. Alison Moskowitz
    151 Moskowitz
  3. Patricia Myskowski
    139 Myskowski
  4. Shamir Geller
    24 Geller